Journal List > Asian Oncol Nurs > v.18(1) > 1095309

Baek and Choi: A Comparative Study on the Characteristics of Cancer Patients and Cancer Survivors

초록

Purpose

The purpose of the study was to identify and compare the characteristics of cancer patients and cancer survivors.

Methods

This study used data from the Korea National and Health Nutrition Examination Survey (2010~2015), conducted by the Center for Disease Control and Prevention. This study included 455 cancer patients and 567 cancer survivors. The data were analyzed by descriptive statistics, t-tests, and χ2.

Results

Cancer survivors were less compliant compared to cancer patients in drinking frequency (χ2=13.12, p ≤.001), drinking volume (χ2=13.35, p=.001) and cancer screening tests (χ2=4.79, p=.029). Cancer patients showed higher body weight change compared to cancer survivors (χ2=7.37, p=.025). There was no difference in quality of life (QoL) between the two groups (t=1.38, p=.169).

Conclusion

This study indicates that cancer survivors have poor living habits and no improvement in QoL compared to cancer patients. Oncology nurses should pay attention to cancer survivors compliance of living habits to prevent secondary cancer and to improve their QoL.

REFERENCES

1. Ministry of Health and Welfare (KR); National Cancer Center (KR). Cancer facts & figures 2014 in the Republic of Korea. Seoul: Ministry of Health and Welfare;2014.
2. Kim P. Cost of cancer care: the patient perspective. J Clin Oncol. 2007; 25:228–32.
crossref
3. Korea Statistics. Cancer registration statistics [Internet]. Available from. http://www.index.go.kr/potal/main/EachDtlPageDetail.do?idx_cd=2770. [Accessed September 28, 2017].
4. Stewart BW, Kleihues P. World cancer report 2003. Lyon: International Agency for Research on Cancer;2003.
5. Parsaie FA, Golchin M, Asvadi I. A comparison of nurse and patient perceptions of chemotherapy treatment stressors. Cancer Nurs. 2000; 23:371–4.
crossref
6. Valdivieso M, Kuiawa AM, Jones T, Baker LH. Cancer survivors in the United States: a review of the literature and a call action. Int J Med Sci. 2012; 9:163–73.
7. Li CI, Daling JR, Porter PL, Tang MT, Malone KE. Relationship between potentially modifiable lifestyle factors and risk of second primary contralateral breast cancer among women diagnosed with estro-gen receptor-positive invasive breast cancer. J Clin Oncol. 2009; 27:5312–8.
crossref
8. Kim YI. Correlations among lifestyle and health status: a comparative study between nurses and clients. J Korean Community Nurs. 1994; 5:53–63.
9. National Cancer Information Center (KR). Guidelines for national cancer prevention [Internet]. Available from. https://www.cancer.go.kr/lay1/S1T200C203/contents.do. [Accessed March 22, 2016].
10. Jung KB. The effect of eating habits and life style on gynecologic cancer [dissertation]. Pocheon: CHA Univ.;2015.
11. Hur HK, Song HY. Comparison of effects of perceived stress and coping patterns on depression between cancer patients and healthy adults. Korean J Hosp Palliat Care. 2008; 11:91–8.
12. An H, Nho JH, Yoo S, Kim H, Nho M, Yoo H. Effect of lifestyle intervention on fatigue, nutritional status and quality of life patients with gynecologic cancer. J Korean Acad Nurs. 2015; 45:812–22.
13. Oh PJ. A structural model for health promotion and quality of life in people with cancer. J Nurs Acad Soc. 1996; 26:632–52.
crossref
14. Kim HY. A comparative study of lifestyle with cancer patients and control group [dissertation]. Jinju: Gyeongsang National Univ.;2011.
15. Do MH, Lee SS, Jung PJ, Lee MH. Relation of breast cancer risk with alcohol consumption and physical activity: a case-control study. Korean J Nutr. 2003; 36:40–8.
16. Yang YH. A path analysis on factors influencing second primary cancer screening practices in stomach, colon, and breast cancer survivors. J Korean Acad Nurs. 2014; 44:139–48.
crossref
17. Lee DC. The proper health care of cancer survivors: present status and importance. Korean J Clin Geriatr. 2012; 13:12–9.
18. Seo JS, Park HA, Kang JH, Kim KW, Cho YG, Hur YI, et al. Obesity and obesity-related lifestyles of Korean breast cancer survivors. Korean J Health Promot. 2014; 14:93–102.
crossref
19. Min HS, Park SY, Lim JS, Park MO, Won HJ, Kim JI. A study on behaviors for preventing recurrence and quality of life in breast cancer survivors. J Korean Acad Nurs. 2008; 38:187–94.
crossref
20. Pinto BM, Trunzo JJ. Health behaviors during and after a cancer diagnosis. Cancer. 2005; 104:2614–23.
crossref
21. Ligibel JA, Denlinger CS. New NCCN guidelines for survivorship care. J Natl Compr Canc Netw. 2013; 11:640–4.
crossref
22. Mayer DK, Terrin NC, Menon U, Kreps GL, McCance K, Parsons SK, et al. Screening practice in cancer survivors. J Cancer Surviv. 2007; 1:17–26.
23. National Center Information Center (KR). Definition of cancer [Internet]. Available from. https://www.cancer.go.kr/lay1/S1T273C274/contents.do. [Accessed February 1, 2013].
24. Feuerstein M. Defining cancer survivorship. J Cancer Surviv. 2007; 1:5–7.
crossref
25. Kim SJ, Lee MC, Kim WJ. The effects of physical activity on cancer pre-vention. Korean J Health Promot Dis Prev. 2008; 8:67–77.
26. Kim CS. Thyroid cancer and radiation. J Korean Thyroid Assoc. 2015; 8:1–7.
crossref
27. Moon YM. Hepatocarcinogenesis. Korean J Gastroenterol. 1993; 25:423–31.
28. Kim NH. Cancer survivors at risk of metabolic disorder. Korean J Obes. 2015; 24:197–8.
crossref
29. Yang SE. Study on the factors related to the non-practice of cancer screening in cancer survivors [dissertation]. Seoul: Yonsei Univ.;2014.
30. Woo HD, Park JS. Performance status and quality life of patients with hematopoietic stem cell transplantation according to period of survival. Asian Oncol Nurs. 2012; 12:132–8.
crossref

Table 1.
Types of Cancers (N =1,022)
Variables Cancer patients (n=455)
Cancer survivors (n=567)
Total
n (%) n (%) n (%)
Gastric cancer 109 (38.4) 171 (44.3) 280 (41.8)
Liver cancer 28 (11.4) 11 (3.5) 39 (6.9)
Colon cancer 70 (25.8) 89 (25.5) 159 (25.6)
Breast cancer 77 (27.7) 96 (26.9) 173 (27.2)
Cervical cancer 19 (7.7) 129 (35.4) 148 (24.3)
Lung cancer 29 (11.6) 12 (3.8) 41 (7.3)
Thyroid cancer 141 (47.3) 67 (20.1) 208 (32.9)

Note. Duplication answer exists.

Table 2.
Demographic Characteristics (N =1,022)
Variables Categories Cancer patients (n=455)
Cancer survivors (n=567)
Total
χ2 or t (p)
n (%) n (%) n (%)
Gender Male 163 (35.8) 175 (30.9) 338 (33.1) 2.81 (.094)
  Female 292 (64.2) 392 (69.1) 684 (66.9)  
Age (year) M ± SD (Range) 61.8 ± 10.7 (40~84) 64.2 ± 10.7 (40~84) 63.1 ± 10.8 (40~84) 16.55 (.002)
  40~49 72 (15.8) 62 (10.9) 134 (13.1)  
  50~59 113 (24.8) 132 (23.3) 245 (24.0)  
  60~69 141 (31.0) 163 (28.8) 304 (29.7)  
  70~79 116 (25.5) 168 (29.6) 284 (27.8)  
  ≥ 80 13 (2.9) 42 (7.4) 55 (5.4)  
Income level Low Middle low 107 (23.5)113 (24.8) 126 (22.2)146 (25.7) 233 (22.8)259 (25.3) 0.40 (.941)
  Middle high 121 (26.6) 151 (26.6) 272 (26.6)  
  High 107 (23.5) 140 (24.7) 247 (24.2)  
  No response 7 (1.5) 4 (0.7) 11 (1.1)  
Education level ≤ Elementary 175 (38.5) 259 (45.7) 434 (42.5) 7.54 (.057)
  Middle 88 (19.3) 83 (14.6) 171 (16.7)  
  High 124 (27.3) 137 (24.2) 261 (25.5)  
  ≥ College 63 (13.8) 84 (14.8) 147 (14.4)  
  No response 5 (1.1) 4 (0.7) 9 (0.9)  
Marriage Married 446 (98.0) 560 (98.8) 1,006 (98.4) 0.91 (.341)
  Single 9 (2.0) 7 (1.2) 16 (1.6)  
National health Self-employed 158 (34.7) 174 (30.7) 332 (32.5) 2.41 (.300)
insurance Employee 273 (60.0) 355 (62.6) 628 (61.4)  
  Medical Care 19 (4.2) 31 (5.5) 50 (4.9)  
  Do not know 1 (0.2) 4 (0.7) 5 (0.5)  
  No response 4 (0.9) 3 (0.5) 7 (0.7)  
Private insurance No 183 (40.2) 288 (50.8) 471 (46.1) 11.80 (.001)
  Yes 267 (58.7) 271 (47.8) 538 (52.6)  
  No response 5 (1.1) 8 (1.4) 13 (1.3)  
Economic activity No 296 (65.1) 328 (57.8) 624 (61.1) 5.53 (.019)
condition Yes 156 (34.3) 235 (41.5) 391 (38.3)  
  No response 3 (0.6) 4 (0.7) 7 (0.7)  
Comorbidity No 418 (91.9) 529 (93.3) 947 (92.7) 0.76 (.384)
  Yes 37 (8.1) 38 (6.7) 75 (7.2)  
Body mass index 18.5 kg/m² 18 (3.9) 37 (6.5) 55 (5.4) 4.25 (.119)
  18.5~25 kg/m² 306 (67.3) 356 (62.8) 662 (64.8)  
  >25 kg/m² 130 (28.6) 174 (30.7) 304 (29.7)  
  No response 1 (0.2)   1 (0.1)  

Note. Not applicable and no answer are excluded from verification.

Table 3.
Health Behavior (N =1,022)
Variables   Categories Cancer patients (n=455)
Cancer survivors (n=567)
Total
χ2 or t (p)
n (%) n (%) n (%)
Current smmoking status No 422 (92.7) 510 (89.9) 932 (91.2) 2.47 (.166)
Yes 33 (7.3) 57 (10.1) 90 (8.8)
Diet Kcal intake Male: <1,900, 220 (48.4) 285 (50.3) 505 (49.4) 1.06 (.590)
Female: <1,600
Male: 1,900~2,500, 103 (22.6) 121 (21.3) 224 (21.9)
Female: 1,600~2,000
Male: >2,500, 104 (22.9) 115 (20.3) 219 (21.4)
Female: >2,000
No response 28 (6.1) 46 (8.1) 74 (7.3)
Fibrin intake <20 262 (57.6) 351 (61.9) 613 (60.0) 3.72 (.156)
(g/day) 20~25 46 (10.1) 48 (8.5) 94 (9.2)
>25 119 (26.2) 122 (21.5) 241 (23.6)
No response 28 (6.1) 46 (8.1) 74 (7.2)
Sodium intake <2,000 108 (23.7) 143 (25.2) 251 (24.6) 0.56 (.454)
(mg/day) >2,000 319 (70.1) 378 (66.7) 697 (68.2)
No response 28 (6.2) 46 (8.1) 74 (7.2)
Fat intake <40 318 (69.9) 401 (70.7) 719 (70.4) 3.09 (.214)
(g/day) 40~50 44 (9.7) 37 (6.5) 81 (7.9)
>50 65 (14.3) 83 (14.7) 148 (14.5)
No response 28 (6.1) 46 (8.1) 74 (7.2)
Protein intake <50 182 (40.0) 242 (42.7) 424 (41.5) 1.57 (.456)
(g/day) 50~55 32 (7.0) 40 (7.0) 72 (7.0)
>55 213 (46.8) 239 (42.2) 452 (44.2)
No response 28 (6.2) 46 (8.1) 74 (7.3)
Number of meals 1 meals 5 (1.1) 2 (0.4) 7 (0.7) 5.24 (.073)
2 meals 20 (4.4) 38 (6.7) 58 (5.7)
3 meals 178 (39.1) 197 (34.7) 375 (36.7)
No response 252 (55.4) 330 (58.2) 582 (56.9)
Breakfast No 28 (6.2) 38 (6.7) 66 (6.5) 0.32 (.572)
Yes 192 (42.2) 224 (39.5) 416 (40.7)
No response 235 (51.6) 305 (53.8) 540 (52.8)
Lunch No 27 (6.0) 31 (5.5) 58 (5.7) 0.00 (.987)
Yes 189 (41.5) 218 (38.4) 407 (39.8)
No response 239 (52.5) 318 (56.1) 557 (54.5)
Dinner No 16 (3.5) 23 (4.1) 39 (3.8) 0.45 (.505)
Yes 198 (43.5) 227 (40.0) 425 (41.6)
No response 241 (53.0) 317 (55.9) 558 (54.6)
Drinking Frequency No 260 (57.1) 261 (46.0) 521 (51.0) 13.12 (<.001)
Once a month 91 (20.0) 143 (25.2) 234 (22.9)
More than twice a month 96 (21.1) 155 (27.4) 251 (24.5)
No response 8 (1.8) 8 (1.4) 16 (1.6)
Volume No 260 (57.1) 261 (46.0) 521 (51.0) 13.34 (.001)
1~2 cup 110 (24.2) 167 (29.5) 277 (27.1)
>3 cup 78 (17.2) 132 (23.3) 210 (20.5)
No response 7 (1.5) 7 (1.2) 14 (1.4)
Exercise Walk for No 234 (51.4) 325 (57.3) 559 (54.7) 2.23 (.136)
1 week Yes 95 (20.9) 103 (18.2) 198 (19.4)
No response 126 (27.7) 139 (24.5) 265 (25.9)
Muscular No 416 (91.4) 511 (90.1) 927 (90.7) 0.32 (.571)
exercise for Yes 35 (7.7) 49 (8.6) 84 (8.2)
1 week No response 4 (0.9) 7 (1.2) 11 (1.1)
Flexibility No 344 (75.6) 425 (75.0) 769 (75.2) 0.01 (.927)
exercise for Yes 107 (23.5) 134 (23.6) 241 (23.6)
1 week No response 4 (0.9) 8 (1.4) 12 (1.2)

Note. Not applicable and no answer are excluded from verification.

Table 3.
Health Behavior (Continued) (N =1,022)
Variables Categories Cancer patients (n=455)
Cancer survivors (n=567)
Total
χ2 or t ( p)
n (%) n (%) n (%)
Weight Weight change No change 285 (62.6) 398 (70.2) 683 (66.8) 7.37 (.025)
Weight loss 94 (20.7) 84 (14.8) 178 (17.4)
Weight gain 69 (15.2) 79 (13.9) 148 (14.5)
No response 7 (1.5) 6 (1.1) 13 (1.3)
Weight control Loss efforts 143 (31.4) 186 (32.8) 329 (32.2) 1.43 (.699)
Maintenance 103 (22.7) 112 (19.8) 215 (21.0)
Gain efforts 41 (9.0) 56 (9.9) 97 (9.5)
Never tried 161 (35.4) 207 (36.5) 368 (36.0)
No response 7 (1.5) 6 (1.0) 13 (1.3)
Exercise No 56 (12.3) 74 (13.1) 130 (12.7) 0.34 (.559)
Yes 190 (41.8) 223 (39.3) 413 (40.4)
Not applicable 202 (44.4) 263 (46.4) 465 (45.5)
No response 7 (1.5) 7 (1.2) 14 (1.4)
Dietary No 122 (26.8) 135 (23.8) 257 (25.1) 0.93 (.336)
Yes 124 (27.3) 162 (28.6) 286 (28.0)
Not applicable 202 (44.4) 263 (46.4) 465 (45.5)
No response 7 (1.5) 7 (1.2) 14 (1.4)
Cancer Cancer screening No 309 (67.9) 385 (67.9) 694 (67.9) 0.00 (.986)
screening within 2 years Yes 144 (31.7) 179 (31.6) 323 (31.6)
No response 2 (0.4) 3 (0.5) 5 (0.5)
General screening No 301 (66.2) 386 (68.1) 687 (67.2) 0.29 (.593)
within 2 years Yes 150 (32.9) 179 (31.6) 329 (32.2)
No response 4 (0.9) 2 (0.3) 6 (0.6)
Personal burden No 214 (47.0) 260 (45.9) 474 (46.4) 0.37 (.541)
cancer screening Yes 93 (20.4) 125 (22.0) 218 (21.3)
Not applicable 144 (31.7) 179 (31.6) 323 (31.6)
No response 4 (0.9) 3 (0.5) 7 (0.7)
Person specific No 171 (37.6) 246 (43.4) 417 (40.8) 4.79 (.029)
cancer screening Yes 136 (29.9) 139 (24.5) 275 (26.9)
Not applicable 144 (31.6) 179 (31.6) 323 (31.6)
No response 4 (0.9) 3 (0.5) 7 (0.7)
National health No 186 (40.9) 211 (37.2) 397 (38.8) 2.33 (.127)
insurance Yes 121 (22.6) 174 (30.7) 295 (28.9)
corporation free Not applicable 144 (31.6) 179 (31.6) 323 (31.6)
cancer screening No response 4 (0.9) 3 (0.5) 7 (0.7)
Free cancer No 305 (67.0) 381 (67.2) 686 (67.1) 0.30 (.585)
screenings Yes 2 (0.4) 4 (0.7) 6 (0.6)
Not applicable 144 (31.7) 179 (31.6) 323 (31.6)
No response 4 (0.9) 3 (0.5) 7 (0.7)
Sleeping ho urs <6 hours 105 (23.1) 121 (21.4) 226 (22.1) 1.70 (.428)
6~8 hours 216 (47.5) 291 (51.3) 507 (49.6)
>8 hours 127 (27.9) 144 (25.4) 271 (26.5)
No response 7 (1.5) 11 (1.9) 18 (1.8)
Stress No 81 (17.8) 127 (22.4) 208 (20.4) 3.29 (.070)
Yes 374 (82.2) 440 (77.6) 814 (79.6)

Note. Not applicable and no answer are excluded from verification.

Table 4.
Quality of Life (N =1,022)
Variables Cancer patients (n=455) Cancer survivors (n=567) Total t (p)
M ± SD M ± SD
Quality of life EQ-5D 1.29 ± 0.71 1.23 ± 0.45 1.26 ± 0.58 1.38 (.169)
Motor ability 1.27 ± 0.49 1.30 ± 0.50 1.29 ± 0.49 -0.82 (.415)
Self-management 1.08 ± 0.28 1.08 ± 0.31 1.08 ± 0.30 -0.16 (.875)
Daily activities 1.21 ± 0.44 1.18 ± 0.43 1.20 ± 0.43 1.11 (.267)
Pain/discomfort 1.39 ± 0.58 1.39 ± 0.58 1.39 ± 0.58 0.19 (.851)
Anxiety/depression 1.20 ± 0.43 1.17 ± 0.40 1.18 ± 0.42 1.34 (.179)

EQ-5D= EuroQol-5 dimension.

TOOLS
Similar articles